These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11775898)

  • 21. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
    Chegini N; Rhoton-Vlasak A; Williams RS
    Fertil Steril; 2003 Sep; 80(3):564-70. PubMed ID: 12969699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system.
    Peloggia A; Petta CA; Bahamondes L; Oliveira-Ribeiro M; Zhang J; Salamonsen L
    Hum Reprod; 2006 May; 21(5):1129-34. PubMed ID: 16436495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 expression in the endometrium and its relationship to bleeding in users of continuous oral contraceptives.
    Maia H; Correia T; Freitas L; Athayde C; Coutinho EM
    Gynecol Endocrinol; 2006 Feb; 22(2):96-100. PubMed ID: 16603435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use.
    Buasang K; Taneepanichskul S
    J Med Assoc Thai; 2009 Mar; 92(3):301-7. PubMed ID: 19301720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users.
    Massai MR; Pavez M; Fuentealba B; Croxatto HB; d'Arcangues C
    Contraception; 2004 Jul; 70(1):47-54. PubMed ID: 15208052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
    Sereepapong W; Chotnopparatpattara P; Taneepanichskul S; Markham R; Russell P; Fraser IS
    Hum Reprod; 2004 Mar; 19(3):547-52. PubMed ID: 14998949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased serum levels of nitric oxide metabolites among users of levonorgestrel-releasing implants [corrected] a possible role in progestin-induced bleeding.
    Shaamash AH; Zakhari MM
    Hum Reprod; 2005 Jan; 20(1):302-6. PubMed ID: 15471931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users.
    Marbaix E; Vekemans M; Galant C; Rigot V; Lemoine P; Dubois D; Picquet C; Henriet P; Twagirayezu P; Sufi S; Eeckhout Y; Courtoy PJ
    Hum Reprod; 2000 Aug; 15 Suppl 3():120-34. PubMed ID: 11041228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in vascular basement membrane in the endometrium of Norplant users.
    Hickey M; Simbar M; Markham R; Young L; Manconi F; Russell P; Fraser IS
    Hum Reprod; 1999 Mar; 14(3):716-21. PubMed ID: 10221702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The measurement of endometrial perfusion in norplant users: a pilot study.
    Hickey M; Carati C; Manconi F; Gannon BJ; Dwarte D; Fraser IS
    Hum Reprod; 2000 May; 15(5):1086-91. PubMed ID: 10783358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding.
    Rogers PA; Plunkett D; Affandi B
    Hum Reprod; 2000 Aug; 15 Suppl 3():78-84. PubMed ID: 11041224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system.
    Oliveira-Ribeiro M; Petta CA; De Angelo Andrade LA; Bahamondes L; Hidalgo MM
    Hum Reprod; 2004 Aug; 19(8):1778-84. PubMed ID: 15192067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium.
    Lau TM; Affandi B; Rogers PA
    Mol Hum Reprod; 1999 Jan; 5(1):57-63. PubMed ID: 10050663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the endometrial changes in Norplant users.
    Wan LS
    Ann N Y Acad Sci; 1997 Sep; 828():108-10. PubMed ID: 9329828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use.
    Phupong V; Sophonsritsuk A; Taneepanichskul S
    Contraception; 2006 Mar; 73(3):253-6. PubMed ID: 16472565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
    Ozalp S; Kabukcuoglu S; Tanir HM
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants.
    Faúndes A; Alvarez F; Brache V; Cochón L
    Hum Reprod; 1998 Jan; 13(1):188-91. PubMed ID: 9512255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen treatment of bleeding irregularities associated with Norplant use.
    Abdel-Aleem H; Shaaban OM; Amin AF; Abdel-Aleem AM
    Contraception; 2005 Dec; 72(6):432-7. PubMed ID: 16307966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmenstrual adverse events associated with subdermal contraceptive implants containing normegestrel and levonorgestrel.
    Arowojolu AO; Ladipo OA
    Afr J Med Med Sci; 2003 Mar; 32(1):27-31. PubMed ID: 15030062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.